Funding Opportunities

NIH Funding Opportunities

Notice of NIAID's Participation in NOT-EB-16-008 "Notice of NIH/BD2K Participation in the Joint NSF/NIH Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD)"
Notice NOT-AI-16-070 from the NIH Guide for Grants and Contracts
Thu, 21 Jul 2016 09:29:48 EST

Notice of Intent to Publish a Funding Opportunity Announcement for Core Centers for Clinical Research (P30)
Notice NOT-AR-17-009 from the NIH Guide for Grants and Contracts
Thu, 21 Jul 2016 12:07:07 EST

Notice of NIDCR Participation on RFA-OD-16-013 "Building Interdisciplinary Research Careers in Women's Health (K12)"
Notice NOT-DE-16-005 from the NIH Guide for Grants and Contracts
Fri, 22 Jul 2016 01:34:33 EST

Notice of Revised Application Instructions for PAR-16-109 "Bridges to the Doctorate (R25)"
Notice NOT-GM-16-113 from the NIH Guide for Grants and Contracts
Fri, 22 Jul 2016 09:53:09 EST

Notice of Revised Application Instructions for PAR-16-110 "Bridges to the Baccalaureate (R25)"
Notice NOT-GM-16-114 from the NIH Guide for Grants and Contracts
Fri, 22 Jul 2016 01:14:04 EST

Notice of NICHD Participation in PAR-16-262 "Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01)"
Notice NOT-HD-16-022 from the NIH Guide for Grants and Contracts
Thu, 21 Jul 2016 09:48:44 EST

NINDS Policy for Submission of Applications Containing Clinical Trials
Notice NOT-NS-16-034 from the NIH Guide for Grants and Contracts
Wed, 20 Jul 2016 09:20:33 EST

Predictors and Determinants of Age-Related Changes in Resiliencies to Physical Stressors in Humans (UH2/UH3)
Funding Opportunity RFA-AG-17-014 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is a phased innovation initiative to enhance clinical tools to assess resiliencies and advance our understanding of age-related changes in resiliencies to physical stressors in humans. Resilience is defined here as the dynamic ability to maintain or recover appropriate function in response to a physical stressor. For the purposes of this FOA, examples of physical stressors include hip fracture, infections, or surgical procedures. Examples of specific resiliencies include recovery of ambulation after a hip fracture, healing of incisional wounds, maintenance or recovery of hematopoietic function after cancer chemotherapy, or maintenance of cognitive function following general anesthesia.
Thu, 21 Jul 2016 12:42:56 EST

Promoting Organ and Tissue Donation Among Diverse Populations (R01)
Funding Opportunity RFA-DK-16-022 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) intends to stimulate investigators to search for barriers to organ and tissue donation. This may include studying individual attitudes, beliefs and behaviors towards organ and tissue transplantation, as well as the need for organ transplantation, among diverse and underserved populations and rural communities. The grant will provide support for testing various hypotheses on the barriers, and facilitate development of programs in the diverse and underserved communities to enhance their understanding of the need, risks and benefits of organ and tissue donation. Successful approaches should ultimately lead to increase in the number of diverse and underserved participating in living and deceased organ donation.
Wed, 20 Jul 2016 09:03:36 EST

Revolutionizing Innovative, Visionary Environmental health Research (RIVER) (R35)
Funding Opportunity RFA-ES-16-008 from the NIH Guide for Grants and Contracts. The NIEHS Revolutionizing Innovative, Visionary Environmental health Research (RIVER) program seeks to provide support for the majority of the independent research program for outstanding investigators in the Environmental Health Sciences, giving them intellectual and administrative freedom, as well as sustained support to pursue their research in novel directions in order to achieve greater impacts. The program seeks to identify individuals, regardless of career stage, with a track record of innovative and impactful research and combine their existing investigator-initiated research into a single seven year award with direct costs of up to $750,000 based on current NIEHS funding.
Thu, 21 Jul 2016 02:37:23 EST

Small Grants on Primary Immunodeficiency Diseases (R03)
Funding Opportunity PA-16-372 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support small grants on primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for primary immunodeficiency diseases. In addition, this FOA aims to encourage analyses of clinical data and samples maintained in primary immunodeficiency registries, consortium databases and repositories to address questions relevant to primary immunodeficiency research. The R03 grant supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. Investigators who have not received independent NIH funding or independent NIH funding in this field are encouraged to apply to this FOA
Tue, 19 Jul 2016 10:47:57 EST

Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21)
Funding Opportunity PA-16-373 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support innovative exploratory/developmental investigations on primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for primary immunodeficiency diseases. In addition, this FOA aims to encourage analyses of clinical data and samples maintained in primary immunodeficiency registries, consortium databases and repositories to address questions relevant to primary immunodeficiency research.
Tue, 19 Jul 2016 10:47:26 EST

Assay Development and Screening to Discover Therapeutic or Imaging Agents for Diseases of Interest to the NIDDK (R01)
Funding Opportunity PA-16-374 from the NIH Guide for Grants and Contracts. Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Thu, 21 Jul 2016 12:26:07 EST

T1 Translational Research on Aging: Small Business Innovation Awards (R43/R44)
Funding Opportunity PAR-16-375 from the NIH Guide for Grants and Contracts. The involvement of small businesses in translational aging research could substantially hasten the pace at which scientific advances are transformed into commercial products to improve or maintain the health and functional independence of older adults. Therefore, this funding opportunity announcement (FOA) is intended to encourage a greater involvement by small businesses through the SBIR mechanism in transforming scientific advances in aging research into novel devices, products, health care practices and programs that will benefit the lives of older adults.
Fri, 22 Jul 2016 09:41:07 EST

T2 Translational Research on Aging: Small Business Innovation Awards (R43/R44)
Funding Opportunity PAR-16-376 from the NIH Guide for Grants and Contracts. The involvement of small businesses in translational aging research could hasten the pace at which scientific advances are transformed into commercial products to improve or maintain the health and functional independence of older adults. Therefore, this funding opportunity announcement (FOA) is intended to support innovative research conducted by small businesses through the SBIR program to advance the availability of novel devices, products, health care practices and programs with the potential for commercial success and the likelihood to benefit the lives of older adults.
Fri, 22 Jul 2016 09:41:04 EST